Key result
Automated data-adaptive propensity score adjustment using both claims and registry data best controlled for confounding by indication, yielding a non-significant hazard ratio of 1.22 for mortality with carotid artery stenting versus endarterectomy.
Why the study?
Confounding by indication threatens comparative real-world studies, prompting evaluation of an automated data-adaptive analytic approach when both claims and clinical registry data are available.
Does carotid artery stenting affect all-cause mortality compared to carotid endarterectomy in Medicare beneficiaries >65 years old?
Observational (n=5,254)
Yes
Does carotid artery stenting affect all-cause mortality compared to carotid endarterectomy in Medicare beneficiaries >65 years old?
Hazard Ratio: 1.22 (95% CI 0.92–1.63)
Absolute Event Rate: 25.5% vs 16.8%
In comparative effectiveness studies with severe confounding by indication, automated data-adaptive propensity score methods using combined claims and clinical registry data provide the most robust adjustment.
Should not yet change carotid revascularization decisions; extends automated propensity methods for confounding control in observational CER.
Background Confounding by indication is a serious threat to comparative studies using real world data. We assessed the utility of automated data-adaptive analytic approach for confounding adjustment when both claims and clinical registry data are available. Methods We used a comparative study example of carotid artery stenting (CAS) vs. carotid endarterectomy (CEA) in 2005-2008 when CAS was only indicated for patients with high surgical risk. We included Medicare beneficiaries linked to the Society for Vascular Surgery’s Vascular Registry >65 years old undergoing CAS/CEA. We compared hazard ratios (HRs) for death while adjusting for confounding by combining various 1) Propensity score (PS) modeling strategies (investigator-specified [IS-PS] vs. automated data-adaptive [ada-PS]); 2) data sources (claims-only, registry-only and claims-plus-registry); and 3) PS adjustment approaches (matching vs. quintiles-adjustment with/without trimming). An HR of 1.0 was a benchmark effect estimate based on CREST trial. Results The cohort included 1,999 CAS and 3,255 CEA patients (mean age 76). CAS patients were more likely symptomatic and at high surgical risk, and experienced higher mortality (crude HR=1.82 for CAS vs. CEA). HRs from PS-quintile adjustment without trimming were 1.48 and 1.52 for claims-only IS-PS and ada-PS, 1.51 and 1.42 for registry-only IS-PS and ada-PS, and 1.34 and 1.23 for claims-plus-registry IS-PS and ada-PS, respectively. Estimates from other PS adjustment approaches showed similar patterns. Conclusions In a comparative effectiveness study of CAS vs. CEA with severe confounding by indication, ada-PS performed better than IS-PS in general, but both claims and registry data were needed to adequately control for bias.
No takes yet. Share an insight, caveat, or question.
Kumamaru et al. (2021) conducted an observational in Carotid artery stenosis (n=5,254). Carotid artery stenting (CAS) vs. Carotid endarterectomy (CEA) was evaluated on Death from any cause (HR 1.22, 95% CI 0.92-1.63). Automated data-adaptive propensity score adjustment using both claims and registry data best controlled for confounding by indication, yielding a non-significant hazard ratio of 1.22 for mortality with carotid artery stenting versus endarterectomy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: